Those play an essential role in secreting type I interferon in the TME [29] and the RT-induced CD8+ T cell anti-tumour effect [30] correlated with the efficacy of immune checkpoint inhibitors (ICI) and RT combinations in GBM [6]. This evidence concerns the gene CD8A and neoplasm.